Pathogenic Nocardia, Rhodococcus, and related organisms are highly susceptible to imidazole antifungals

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 4, 2003, Pages 1476-1478

  Dabbs, Eric R ^a   Naidoo, Samantha ^a   Lephoto, Catherine ^a   Nikitina, Natalya ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; BIFONAZOLE; CLOTRIMAZOLE; ECONAZOLE; IMIDAZOLE DERIVATIVE; KETOCONAZOLE; VORICONAZOLE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; CULTURE MEDIUM; FUNGUS CULTURE; FUNGUS ISOLATION; MINIMUM INHIBITORY CONCENTRATION; MYCETOMA; NOCARDIA; NONHUMAN; PRIORITY JOURNAL; RHODOCOCCUS;

ANTIFUNGAL AGENTS; CLOTRIMAZOLE; FLUCONAZOLE; IMIDAZOLES; MICONAZOLE; MICROBIAL SENSITIVITY TESTS; NOCARDIA; RHODOCOCCUS;

EID: 0037379527     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.4.1476-1478.2003     Document Type: Article

References (26)

1. Akan, H., M. Akova, H. Ataoglu, G. Aksu, O. Arslan, and H. Koc. 1998. Rhodococcus equi and Nocardia brasiliensis infection of the brain and liver in a patient with acute nonlymphoblastic leukemia. Eur. J. Clin. Microbiol. Infect. Dis. 17:737-739.
2. Bemer-Melchior, P., A. Haloun, P. Riegel, and H. B. Drugeon. 1998. Bacteremia due to Dietzia maris in an immunocompromised patient. Clin. Infect. Dis. 29:1340-1341.
3. Clark, N. M., D. K. Braun, A. Pasternak, and C. E. Chenoweth. 1995. Primary, cutaneous Nocardia otitidiscaviarum infection: case report and review. Clin. Infect. Dis. 20:1266-1270.
4. Clotet, B., G. Sierra, and A. Erice. 1993. Rhodococcus equi infection in HIV-infected patients. J. Acquir. Immune Defic. Syndr. 6:429-430.
5. Finkelstein, A., and R. Holz. 1973. Aqueous pores created in thin lipid membranes by the polyene antibiotics nystatin and amphotericin B. Membranes 2:377-408.
6. Georgopapadakou, N. H., and T. J. Walsh. 1996. Antifungal agents: chemotherapeutic targets and immunological strategies. Antimicrob. Agents Chemother. 40:279-291.
7. Guardiola-Diaz, H. M., L. A. Foster, D. Mushrush, and A. D. Vaz. 2001. Azole-antifungal binding to a novel cytochrome P450 from Mycobacterium tuberculosis: implications for treatment of tuberculosis. Biochem. Pharmacol. 61:1463-1470.
8. Hachem, R., I. Raad, K. V. Rolston, E. Whimbey, R. Katz, J. Tarrand, and H Libshitz. 1996. Cutaneous and pulmonary infections caused by Mycobacterium vaccae. Clin. Infect. Dis. 23:173-175.
9. Harvey, R. L., and J. C. Sunstrum. 1991. Rhodococcus equi infection in patients with and without human immunodeficiency virus infection. Rev. Infect. Dis. 13:139-145.
10. Hondalus, M. K. 1997. Pathogenesis and virulence of Rhodococcus equi. Vet. Microbiol. 56:257-268.
11. Hsueh, P. R., C. C. Hung, L. J. Teng, M. C. Yu, Y. C. Chen, H. K. Wang, and K. T. Luh. 1998. Report of invasive Rhodococcus equi infections in Taiwan, with an emphasis on the emergence of multidrug-resistant strains. Clin. Infect. Dis. 27:370-375.
12. Irwin, L. L., and L S. Rickman. 1995. New, unfamiliar drugs for suspected drug-resistant tuberculosis. Infect. Med. 12:32-39.
13. Jackson, C. J., D. C. Lamb, D. E. Kelly, and S. L Kelly. 2000. Bactericidal and inhibitory effects of azole antifungal compounds on Mycobacterium smegmatis. FEMS Microbiol. Lett. 192:159-162.
14. Lamp, K. C., C. D. Freeman, N. E. Klutman, and M. K. Lacy. 1999. Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials. Clin. Pharmacokinet. 36:353-373.
15. Nordmann, P., E. Rouveix, M. Guenounou, and M. H. Nicolas. 1992. Pulmonary abscess due to a rifampin and fluoroquinolone resistant Rhodococ. cus equi strain in a HIV infected patient. Eur. J. Clin. Microbiol. Infect. Dis. 11:557-558.
16. Palestine, R. F., and R. S. Rogers. 1982. Diagnosis and treatment of mycetoma. J. Am. Acad. Dermatol. 6:107-111.
17. Pidoux, O., J. N. Argenson, V. Jacomo, and M. Drancourt. 2001. Molecular identification of a Dietzia maris hip prosthesis infection isolate. J, Clin. Microbiol. 39:2634-2636.
18. Richet, H. M., P. C. Craven, J. M. Brown, B. A. Lasker, C. D. Cox, M. M. McNeil, A. D. Tice, W. R. Jarvis, and O. C. Tablan. 1991. A cluster of Rhodococcus (Gordona) bronchialis sternal-wound infections after coronaryartery bypass surgery. N. Engl. J. Med. 324:104-109.
19. Sabo, J. A., and S. M. Abdel-Rahman. 2000. Voriconazole: a new triazole antifungal. Ann. Pharmacother. 34:1032-1043.
20. Salinas-Carmona, M. C. 2000. Nocardia brasiliensis: from microbe to human and experimental infections. Microbes Infect. 2:1373-1381.
21. Sarzier, J. S., J. N. Greene, R. L. Sandin, A. S. Spiers, P. J. Emmanuel, R. E. Valder, M. E. Gombert, and A. L. Vincent. 1998. Disseminated Nocardia brasiliensis infection in an immuno-compromised patient. Cancer Control 5:64-67.
22. Sud, I. J., and D. S. Feingold. 1982. Action of antifungal imidazoles on Staphylococcus aureus. Antimicrob. Agents Chemother. 22:470-474.
23. Sun, Z., and Y. Zhang. 1999. Antituberculosis activity of certain antifungal and antihelmintic drugs. Tuber. Lung Dis. 79:319-320.
24. von Reeklinghausen, G., C. Di Maio, and R. Ansorg. 1993. Activity of antibiotics and azole antimycotics against Helicobacter pylori. Zentbl. Bakteriol. 280:279-285.
25. Yazawa, K., Y. Mikami, A. Maeda, M. Akao, N. Morisaki, and S. Iwasaki. 1993. Inactivation of rifampin by Nocardia brasiliensis. Antimicrob. Agents Chemother. 37:1313-1317.
26. Yoshida, Y. 1988. Cytochrome P450 of fungi: primary target for azole antifungal agents. Curr. Top. Med. Mycol. 2:388-418.